The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...

Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...

Today’s White House MAHA Commission report is expected to pull punches on pesticide regulation as Bayer lobbies to limit ...

German pharmaceutical giant Bayer said Tuesday it had struck a deal valued at up to $1.3 billion (1.1 billion euros) with a US ...

From a new frontman at Old Trafford to a potential goalkeeping merry-go-round and a big Liverpudlian exit, here are 10 of the ...

Our weekly round-up of U.S. players' contributions across Europe begins with a look at how they fared in this weekend's ...

Bayer Leverkusen’s Julian Brandt is one of the wide candidates under consideration by Liverpool should they strengthen their ...

Ademola Lookman has reportedly rejected the idea of joining Arsenal, as he is waiting for another move by Inter Milan.This ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

Chelsea attacker Estevao Willian enjoyed an unofficial debut to remember at Stamford Bridge. The 18-year-old scored and gave ...

We’ve seen just a few games from Joao Pedro in a Chelsea shirt so far, but he’s already shown off a crazy variety of finishes ...